PR PDRN 10 G (POLYDEOXYRIBONUCLEOTIDE SODIUM) Trademark

Trademark Overview


On Wednesday, November 12, 2025, a trademark application was filed for PR PDRN 10 G (POLYDEOXYRIBONUCLEOTIDE SODIUM) with the United States Patent and Trademark Office. The USPTO has given the PR PDRN 10 G (POLYDEOXYRIBONUCLEOTIDE SODIUM) trademark a serial number of 99492708. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Wednesday, November 12, 2025. This trademark is owned by Pharmaresearch Co., Ltd.. The PR PDRN 10 G (POLYDEOXYRIBONUCLEOTIDE SODIUM) trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparation for skin care; Medicated skin preparation for use in treating skin disorders; Creams for dermatological use; Medicated creams for treating dermatological conditions; Medicinal creams for skin care; Anti-itch ointment; Medicated body care preparations, namely, antiseptic ointments; Medicated body care preparations, namely, ointments for pharmaceutical purposes
pr pdrn 10 g (polydeoxyribonucleotide sodium)

General Information


Serial Number99492708
Word MarkPR PDRN 10 G (POLYDEOXYRIBONUCLEOTIDE SODIUM)
Filing DateWednesday, November 12, 2025
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateWednesday, November 12, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical preparation for skin care; Medicated skin preparation for use in treating skin disorders; Creams for dermatological use; Medicated creams for treating dermatological conditions; Medicinal creams for skin care; Anti-itch ointment; Medicated body care preparations, namely, antiseptic ointments; Medicated body care preparations, namely, ointments for pharmaceutical purposes
Description of MarkThe mark consists of a stylized letter P in green and a stylized letter R in pink. To the right of the "PR" are Korean characters in green that transliterate to "Rejuvenex" and below those Korean characters and Korean characters in black, within black parentheses, transliterate to "Polydeoxvribonucloetide-Natrium". To the right of "Rejuvenex" in Korean characters is a box in black that includes Korean characters in green that transliterate to CREAM, and to the right of that are the letters PDRN in green with the phrase "(Polydeoxyribonucleotide sodium)" in green. To the right and below the letters "PDRN" is the phrase "10g" in green. All of the above appear on top of a thin green line and a thick pink line.
NOT AVAILABLE"Polydeoxyribonucleotide sodium"
NOT AVAILABLEThe Korean characters in this mark transliterate to Rejuvenex and this has no meaning in a foreign language. The Korean characters in this mark transliterate to CREAM and this means Cream in English. The Korean characters in this mark transliterate to Polydeoxvribonucloetide-Natrium and this means Polydeoxyribonucleotide sodium in English.
Indication of Colors claimedThe color(s) green, pink, black is/are claimed as a feature of the mark.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, November 12, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePharmaresearch Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGangwon-do 25452
KR

Trademark Events


Event DateEvent Description
Wednesday, November 12, 2025NEW APPLICATION ENTERED
Wednesday, November 12, 2025APPLICATION FILING RECEIPT MAILED